Dianthus Therapeutics, Inc. /DE/ Operating Leases, Future Minimum Payments, Due in Three Years
Dianthus Therapeutics, Inc. /DE/ (DNTH) had Operating Leases, Future Minimum Payments, Due in Three Years of $7.68 million as of 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears · last filed 2023-03-23
- 2022-03-31: Operating Leases, Future Minimum Payments, Due in Three Years $7.68M.
- 2021-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $7.10M.
- 2021-09-30: Operating Leases, Future Minimum Payments, Due in Three Years $7.10M.
- 2021-06-30: Operating Leases, Future Minimum Payments, Due in Three Years $7.10M.
| Period end | Operating Leases, Future Minimum Payments, Due in Three Years |
|---|---|
| 2022-03-31 | $7.68M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $7.10M 10-K · filed 2023-03-23 |
| 2021-09-30 | $7.10M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $7.10M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $6.73M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $6.73M 10-K · filed 2021-03-03 |
| 2020-09-30 | $6.38M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $6.38M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $6.38M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $6.38M 10-K · filed 2020-03-03 |
| 2019-09-30 | $6.07M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $6.07M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $6.07M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $5.76M 10-K · filed 2019-03-19 |
| 2018-09-30 | $5.60M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $5.60M 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |